(PubMed) Beard J
[DOI] [PubMed] [Google Scholar] 40.Schirra J, Sturm K, Leicht P, Arnold R, Gke B, Katschinski M
2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S
DigenioADunbarRLAlexanderVJHompeschMMorrowLLeeRGet al
A healthy lifestyle, including good sleep hygiene, balanced nutrition and regular exercise, remains essential for protecting your cells from damage.
Tissue repair, inflammation, skin quality, hair health